Back to mobile site

Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB)

December 18, 2025 5:57 AM EST Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $20.00 price target on Q32 Bio Inc. (NASDAQ: QTTB).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login